Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Lei, H., Juan, A
It is an unapproved research chemical , not a medicine: its only controlled human trial (a Phase II study in postoperative ileus) failed its primary endpoint and development was discontinued, so the popular muscle, fat-loss, anti-aging, recovery and sleep claims are not proven in controlled human outcome trials presented for research and educational use only
Cost-benefit analysis helps assess whether continued annual therapy provides sufficient value relative to investment
Independent vials of each compound
Management: Limit use to 46 week cycles with at least equal time off Consider using GH peptides like GHRP2 or CJC1295 during off cycles to maintain baseline IGF-1 activity Risk of Unwanted Growth (Organs, Gut, Tumors) Long-term, excessive IGF1 can theoretically increase the risk of visceral organ growth , insulin resistance , or even tumor promotion , due to its role in cell proliferation
US$ 22.27
US$ 23.92
US$ 27.66
US$ 21.23
US$ 24.85
